Skip to main content
. 2018 Feb 5;2(1):e29. doi: 10.1097/HS9.0000000000000029

Figure 2.

Figure 2

Molecular screening for CALR mutation. Screening for CALR mutation was performed by fragment analysis at diagnosis of CML (panel A), and 3 months later when the thrombocytosis appeared (panel B). Digital PCR at the time of diagnosis of CML was able to detect the CALR type 1 mutation with a VAF of 0.8% (panel C). VAF = variant allele frequency, WT = wild-type allele.